LMO3 |
SAMD3 |
||
---|---|---|---|
Gene Name | LIM domain only 3 (rhombotin-like 2) | sterile alpha motif domain containing 3 | |
Image | No pdb structure | No pdb structure | |
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process |
|
||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS |
|
||
Protein-Protein Interactions | 33 interactors: AIMP2 BANP CARF CCDC33 CCDC85B CEP170P1 CEP57L1 FAM131C FBLIM1 FOS GABPB1 HNRNPC HNRNPM IKZF1 KCTD1 KXD1 LDB1 LDB2 MBIP MDFI NBPF22P NHLH2 NUTM1 PHC2 RALYL RFX6 RORA SAMD3 SP4 SPERT TAX1BP1 ZBTB43 ZBTB8A | 7 interactors: AKAP9 C6orf165 FANCG HSPD1 KDM1A LMO3 PRMT1 | |
Entrez ID | 55885 | 154075 | |
HPRD ID | 11832 | 11530 | |
Ensembl ID | ENSG00000048540 | ENSG00000164483 | |
Uniprot IDs | Q8TAP4 Q9NYC6 | B4DY20 J3KQK4 Q8N6K7 | |
PDB IDs | |||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | aggressive
aggressiveness
atypical
benign
biosignatures
clinically
constitute
decisions
demand
forty
fourteen
histologically
igf1r
meningioma
meningiomas
metabolic
mostly
nmr
oligonucleotide
otherwise
predominant
proceeds
profiles
recur
recurrence
relevance
subgroup
subgroups
turnover
|
adjacent
androgen
androgens
antagonistic
antagonistically
ar
btg1
cdca7l
cdk6
chip
confirming
depends
find
htgp
immunoprecipitation
mapped
position
prostate
proved
publicly
ra
rar
rare
responsive
restricted
retinoic
seq
tgm4
transactivation
|
|
Tagcloud (Difference) ? | aggressive
aggressiveness
atypical
benign
biosignatures
clinically
constitute
decisions
demand
forty
fourteen
histologically
igf1r
meningioma
meningiomas
metabolic
mostly
nmr
oligonucleotide
otherwise
predominant
proceeds
profiles
recur
recurrence
relevance
subgroup
subgroups
turnover
|
adjacent
androgen
androgens
antagonistic
antagonistically
ar
btg1
cdca7l
cdk6
chip
confirming
depends
find
htgp
immunoprecipitation
mapped
position
prostate
proved
publicly
ra
rar
rare
responsive
restricted
retinoic
seq
tgm4
transactivation
|
|
Tagcloud (Intersection) ? |